Clinical Trial Update: Vorinostat and Concurrent Whole Brain Radiotherapy for Brain Metastasis [Phase 2]

View source ↗

Summary

Phase 2 trial of Vorinostat with concurrent whole brain radiotherapy for brain metastasis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastasis

Drugs mentioned

• Vorinostat (vorinostat)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Brain Metastasis | Phase 2 | Status: TERMINATED